Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BRKRthis companyBruker Corporation	$66.18	-314.07×	2.91×	2.08×	29.4×	-38.9%	45.9%	6.9%	-0.3%	-0.4%	-1.9%	0.2%	0.83×	5.76×	3.91×	1.73×	0.3%	5	2.75	1	C-
AAgilent Technologies, Inc.	$178.86	31.89×	6.14×	5.96×	23.43×	-60.2%	52.4%	21.3%	18.8%	19.3%	12.6%	2.8%	0.5×	0.85×	13.21×	1.96×	0.7%	6	5.82	3	B+
BIOBio-Rad Laboratories, Inc.	$394.07	10.87×	1.11×	3.2×	7.65×	-146.4%	52.0%	10.5%	29.4%	10.2%	2.0%	4.5%	0.21×	0.83×	5.52×	5.62×	0.0%	7	3.65	3	B
DHRDanaher Corporation	$233.39	45.15×	3.08×	6.59×	25.3×	-14.1%	60.9%	20.9%	14.7%	6.9%	5.7%	3.2%	0.35×	1.99×	19.38×	1.87×	0.5%	7	3.74	3	B
MTDMettler-Toledo International Inc.	$1,751.17	33.06×	-1,215.71×	7.14×	24.95×	-61.5%	59.4%	27.8%	21.6%	-3677.4%	35.5%	3.0%	-99.14×	1.83×	16.32×	1.14×	0.0%	7	11.4	3	B
PACBPacific Biosciences of California, Inc.	$2.34	-1.03×	104.87×	3.51×	-8.23×	-472.5%	31.7%	-348.5%	-341.5%	-10214.5%	-76.4%	-20.3%	142.07×	-4.56×	-80.18×	6.89×	0.0%	2	-4.47	2	B-
Peer median	—	31.89×	3.08×	5.96×	23.43×	-61.5%	52.4%	20.9%	18.8%	6.9%	5.7%	3.0%	0.35×	0.85×	13.21×	1.96×	0.0%	7	3.74	3	—